Dr. Franklin has had a distinguished career as a researcher, educator and regulator. After joining Health Canada, she was involved in the regulation of consumer products, environmental chemicals, pharmaceuticals and pesticides. In 1995, Dr. Franklin became the first Executive Director of the Pest Management Regulatory Agency.
After leaving Health Canada, she joined the LifeLine Group and is now its President. The LifeLine Group is a non-profit organization dedicated to the development of software tools for assessing exposure, conducting risk assessments to xenobiotics as well as assessing the benefits of dietary nutrients. A more recent area of research in the company is environmental justice involving working with communities hit by catastrophic weather events such as hurricanes.
She is currently on faculty at the Cyprus International Institute in the Harvard School of Public Health-Cyprus University of Technology Program for the Environment and Public Health where she teaches regulatory toxicology and exposure to chemicals. She is currently a member of the International Society of Exposure Sciences.
Dr. Moride has a strong track record of methodological expertise in pharmacoepidemiology and therapeutic risk management. She is President of YolaRx Consultants, a private consulting and research organization with a wide client base in the US, EU, and Canada.
She is Full Professor at UniversitÚ de MontrÚal and Visiting Professor at the University of Bordeaux. She is the former President of the International Society for Pharmacoepidemiology (ISPE) and currently is Vice-President of the International Society of Pharmacovigilance (ISoP).
She is a member of advisory panels at Health Canada, the World Health Organization (WHO), and the European Network of Centres of Pharmacoepidemiology and Pharmacovigilance (ENCePP) at the European Medicines Agency (EMA).
She received a PhD in Epidemiology from McGill University, and a Post-doctoral Fellowship in Pharmacovigilance from the University of Bordeaux.
Christopher Loomis received his Ph.D. in Pharmacology & Toxicology from Queen's University in 1983, where he held a joint appointment as assistant professor in the Department of Pharmacology & Toxicology, and the Department of Anesthesia. In 1988, Dr. Loomis moved to Memorial University of Newfoundland as associate professor of Pharmacology in the School of Pharmacy and the Faculty of Medicine. He was appointed full professor in 1996, and became director of the School of Pharmacy (decanal equivalent) in 1998. Beginning in 2002, Dr. Loomis served two terms as Vice-President (Research) of Memorial University. He also served as Vice-President (Academic) Pro Tempore, and President & Vice-Chancellor Pro Tempore from 2008-2010.
Funded primarily by the Medical Research Council of Canada (MRC) for more than twenty years, Dr. Loomis' program of research focused on the spinal pharmacology of pain (opioid and non-opioid mechanisms of spinal analgesia) and the central mechanisms of neuropathic pain early after nerve injury.
He is a former member and officer of several MRC peer-review committees, and recently completed two terms on the Governing Council of the Canadian Institutes of Health Research (CIHR). He is a past member of the Advisory Council of Rx&D's Health Research Foundation, and the Pharmacy Examining Board of Canada's Panel of Examiners. Dr. Loomis was elected Fellow of the Canadian Academy of Health Sciences in 2012.
Dr. Tyrrell is Distinguished University Professor of Medicine and Medical Microbiology and Immunology at the University of Alberta as well as CIHR/GSK Chair in Virology. He is the Director of the Li Ka Shing Institute of Virology. Previously he was Dean of the Faculty of Medicine and Dentistry (1994-2004), and Chairman of the Department of Medical Microbiology and Infectious Diseases, University of Alberta.
He obtained his BSc in Chemistry and his MD at the University of Alberta and his Ph.D. in Pharmacology at Queen's University, Kingston, Ontario. He was an MRC Centennial Fellow at the Karolinska Institute, Stockholm, Sweden, and a Fellow in Infectious Diseases and Internal Medicine at the University of Alberta.
Dr. Tyrrell is a member of the College of Physicians and Surgeons of Alberta and the Royal College of Physicians and Surgeons of Canada. Dr. Tyrrell is the Chair of the Board of the Gairdner Foundation and the Chair of the Board of the Institute of Health Economics. He is a member of the Royal Society of Canada.
Jack Gauldie, is Distinguished University Professor at McMaster University where he has conducted his research in immunology, inflammation, infectious diseases and vaccine development for the past 40 years.
He was Chair of the Department of Pathology and Molecular Medicine, encompassing both clinical laboratory medicine and basic biomedical research, from 1989 to 2004. He is currently the Director of the Institute for Molecular Medicine and Health in the Faculty of Health Sciences.
He holds a Ph.D. from University College London and is a Fellow of the Royal Society (Canada) and the Royal College of Physicians (Edinburgh).
He was a member of the Advisory Board of the Institute for Infection and Immunity of the Canadian Institutes for Health Research (CIHR) and is Chair of the Advisory Board of Ontario Research Fund and was Co-Chair of the Medical Review Panel of the Gairdner Foundation.
He has published over 370 scientific articles and a number of book chapters, mainly dealing with the areas of biomedical research including immunology, pathology, infectious disease and cancer. He has received awards from the Canadian Society for Immunology, the Canadian Medical Association and the Canadian Society of Clinical Chemists and is a frequent evaluator for granting agencies including CIHR, the National Institutes of Health (U.S.) and the Medical Research Council (UK).
Professor Caulfield is a Canada Research Chair in Health Law and Policy and a Professor in the Faculty of Law and the School of Public Health at the University of Alberta. He has been the Research Director of the Health Law Institute at the University of Alberta since 1993. Over the past several years he has been involved in a variety of interdisciplinary research endeavours that have allowed him to publish over 250 articles and book chapters.
Professor Caulfield has won numerous academic awards including being named a Fellow of the Trudeau Foundation, the Royal Society of Canada and the Canadian Academy of Health Sciences. He has been the Principal Investigator for a number of large interdisciplinary projects that explore the ethical, legal and health policy issues associated with a range of topics, including stem cell research, genetics, patient safety, the prevention of chronic disease, obesity policy, the commercialization of research, complementary and alternative medicine and access to health care.
Professor Caulfield is and has been involved with a number of national and international policy and research ethics committees, including: Canadian Biotechnology Advisory Committee; Genome Canada's Science Advisory Committee; the Ethics and Public Policy Committee for International Society for Stem Cell Research; and the Federal Panel on Research Ethics. He writes frequently for the popular press on a range of health and science policy issues and is the author of The Cure for Everything: Untangling the Twisted Messages about Health, Fitness and Happiness (Penguin 2012).